CompletedPhase 3

Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure

United States42 participantsStarted 2022-08-09

Plain-language summary

The purpose of this study is to investigate whether protocolized vasopressor use for patients with normal blood pressure undergoing rapid sequence intubation improves hemodynamic parameters and mitigates adverse events. The hypothesis is that use of vasopressors during Rapid Sequence Intubation will prevent substantial decreases in blood pressure when compared to normal intravenous fluids.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Respiratory Failure Requiring Intubation Exclusion Criteria: * Pregnancy * Patients intubated during code blue clinical scenarios * Requiring surgical airway * Failed intubations * MAP less than 65 or Systolic Blood Pressure (SBP) less than 90mmHg pre-intubation * Systolic blood pressure greater than 150mmHg * Prisoners

What they're measuring

Systolic Blood Pressure

Timeframe: 1 hour after Rapid Sequence Intubation

Trial details

NCT IDNCT05355974

SponsorWright State University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-10

View on ClinicalTrials.gov More Respiratory Failure trials